Shareholders
Ownership structure and shareholding information
Total: 100.00% of shares
| Shareholder Name | Ownership % ↓ | Share Count | Share Type | Date |
|---|---|---|---|---|
| Oxford Science Enterprises Plc Company | 174,133 | Ordinary | 22 Apr 2025 | |
| Oxford Science Enterprises Plc Company | 84,589 | Preferred Ordinary | 22 Apr 2025 | |
| Orbimed Private Investments Viii, Lp Company | 49,229 | B Preferred | 22 Apr 2025 | |
| Gv 2017, L.p Company | 38,301 | A Preferred | 22 Apr 2025 | |
| Oxford Science Enterprises Plc Company | 36,687 | B Preferred | 22 Apr 2025 | |
| Redmile Biopharma Investments I, L.p Company | 31,118 | A Preferred | 22 Apr 2025 | |
| Redmile Biopharma Investments I, L.p Company | 28,722 | B Preferred | 22 Apr 2025 | |
| Blue Owl Healthcare Opportunities Ii Lp Company | 28,544 | A Preferred | 22 Apr 2025 | |
| Oxford Science Enterprises Plc Company | 26,536 | A Preferred | 22 Apr 2025 | |
| Eli Lilly And Company | 23,791 | B Preferred | 22 Apr 2025 | |
| Raf, L.p Company | 23,790 | B Preferred | 22 Apr 2025 | |
| The Chancellor, Masters And Scholars Of The University Of Oxford Company | 23,774 | Ordinary | 22 Apr 2025 | |
| Raf, L.p Company | 19,947 | A Preferred | 22 Apr 2025 | |
| Invus Public Equities, L.p Company | 16,646 | B Preferred | 22 Apr 2025 | |
| Gv 2019, L.p Company | 16,411 | B Preferred | 22 Apr 2025 | |
| Panacea Venture Healthcare Fund I, L.p Company | 15,922 | A Preferred | 22 Apr 2025 | |
| Samir El Andaloussi | 14,000 | Ordinary | 22 Apr 2025 | |
| Per Lundin | 14,000 | Ordinary | 22 Apr 2025 | |
| Matthew John Andrew Wood | 14,000 | Ordinary | 22 Apr 2025 | |
| Blue Owl Healthcare Opportunities Ii Lp Company | 13,598 | B Preferred | 22 Apr 2025 | |
| Panacea Venture Healthcare Fund I, L.p Company | 7,444 | B Preferred | 22 Apr 2025 | |
| Skyviews Life Science Limited Company | 6,383 | A Preferred | 22 Apr 2025 | |
| Vox Health Fund, Lp Company | 5,307 | A Preferred | 22 Apr 2025 | |
| Kayhan Mirza | 4,365 | A Preferred | 22 Apr 2025 | |
| Franklin M. Berger | 4,103 | A Preferred | 22 Apr 2025 | |
| Skyviews Life Science Limited Company | 3,057 | B Preferred | 22 Apr 2025 | |
| Vox Health Fund. Lp Company | 2,247 | B Preferred | 22 Apr 2025 | |
| Sarah Lucinda Gordon Wild | 2,182 | A Preferred | 22 Apr 2025 | |
| Antonin Robert Rollet De Fougerolles | 2,182 | A Preferred | 22 Apr 2025 | |
| Blue Owl Healthcare Opportunities Ef Ii, Lp Company | 2,095 | A Preferred | 22 Apr 2025 | |
| Kayhan Mirza | 2,041 | B Preferred | 22 Apr 2025 | |
| Franklin M. Berger | 1,918 | B Preferred | 22 Apr 2025 | |
| The Chancellor, Masters And Scholars Of The University Of Oxford Company | 1,643 | B Preferred | 22 Apr 2025 | |
| The Chancellor, Masters And Scholars Of The University Of Oxford Company | 1,309 | A Preferred | 22 Apr 2025 | |
| Sarah Lucinda Gordon Wild | 1,020 | B Preferred | 22 Apr 2025 | |
| Antonin Robert Rollet De Fougerolles | 1,020 | B Preferred | 22 Apr 2025 | |
| Blue Owl Healthcare Opportunities Ef Ii, Lp Company | 998 | B Preferred | 22 Apr 2025 | |
| Per Lundin | 262 | A Preferred | 22 Apr 2025 | |
| Jody-ann Chambers | 95 | Ordinary | 22 Apr 2025 | |
| Luke Haslett | 75 | Ordinary | 22 Apr 2025 | |
| Zera Huixuan Ong | 50 | Ordinary | 22 Apr 2025 | |
| Polly Rebecca Weston | 50 | Ordinary | 22 Apr 2025 | |
| Viren Patel | 25 | Ordinary | 22 Apr 2025 | |
| Emma Louise Koncewicz | 25 | Ordinary | 22 Apr 2025 | |
| Claudia Angela Phoebe Hill | 10 | Ordinary | 22 Apr 2025 |